Cargando…
Tumoricidal Activity of RNase A and DNase I
In our work the antitumor and antimetastatic activities of RNase A and DNase I were studied using two murine models of pulmonary (Lewis lung carcinoma) and liver (hepatoma A–1) metastases. We found that intramuscular administration of RNase A at the dose range of 0.1–50 µ g/kg retarded the primary t...
Autores principales: | Patutina, O.A., Mironova, N.L., Ryabchikova, E.I., Popova, N.A., Nikolin, V.P., Kaledin, V.I., Vlassov, V.V., Zenkova, M.A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
A.I. Gordeyev
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3347544/ https://www.ncbi.nlm.nih.gov/pubmed/22649632 |
Ejemplares similares
-
New Approaches for Cancer Treatment: Antitumor Drugs Based on Gene-Targeted Nucleic Acids
por: Patutina, O.A., et al.
Publicado: (2009) -
The siRNA targeted to mdr1b and mdr1a mRNAs in vivo sensitizes murine lymphosarcoma to chemotherapy
por: Patutina, Olga A, et al.
Publicado: (2010) -
Peptide-oligonucleotide conjugates exhibiting pyrimidine-X cleavage specificity efficiently silence miRNA target acting synergistically with RNase H
por: Patutina, O. A., et al.
Publicado: (2018) -
The systemic tumor response to RNase A treatment affects the expression of genes involved in maintaining cell malignancy
por: Mironova, Nadezhda, et al.
Publicado: (2017) -
RNase T1 mimicking artificial ribonuclease
por: Mironova, N. L., et al.
Publicado: (2007)